Arcturus (ARCT), Moderna (MRNA), and Merck (MRK) fall after a mid-stage trial setback for a cancer shot developed by BioNTech (BNTX)
https://seekingalpha.com/news/4637973-arcturus-moderna-down-biontech-trial-setback
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.